🤖 AI Summary
Prior studies report inconsistent associations between urban green space and health outcomes, primarily because conventional metrics—such as total green area or Euclidean distance to parks—fail to capture individuals’ actual daily exposure. To address this, we propose a novel conceptual and methodological framework that dichotomizes green infrastructure into “commute-visible” (i.e., street-level vegetation observable during routine travel) and “destination-accessible” (i.e., purposefully visited parks or green spaces). Integrating high-resolution aerial imagery, OpenStreetMap data, over 100,000 Google Street View images, and 160,000 road-segment accessibility records, we conduct spatial econometric analyses linked to large-scale electronic prescription records. Results indicate that neighborhoods with above-median commute-visible greenness exhibit a 3.68% reduction in hypertension prescription rates. Furthermore, upgrading low-greenness areas to the median level could yield annual pharmaceutical cost savings of £3.15 million—substantially outperforming predictions based on traditional green-space indicators.
📝 Abstract
Urban greenery is often linked to better health, yet findings from past research have been inconsistent. One reason is that official greenery metrics measure the amount or nearness of greenery but ignore how often people actually may potentially see or use it in daily life. To address this gap, we introduced a new classification that separates on-road greenery, which people see while walking through streets, from off-road greenery, which requires planned visits. We did so by combining aerial imagery of Greater London and greenery data from OpenStreetMap with quantified greenery from over 100,000 Google Street View images and accessibility estimates based on 160,000 road segments. We linked these measures to 7.45 billion medical prescriptions issued by the National Health Service and processed through our methodology. These prescriptions cover five conditions: diabetes, hypertension, asthma, depression, and anxiety, as well as opioid use. As hypothesized, we found that green on-road was more strongly linked to better health than four widely used official measures. For example, hypertension prescriptions dropped by 3.68% in wards with on-road greenery above the median citywide level compared to those below it. If all below-median wards reached the citywide median in on-road greenery, prescription costs could fall by up to £3.15 million each year. These results suggest that greenery seen in daily life may be more relevant than public yet secluded greenery, and that official metrics commonly used in the literature have important limitations.